Remission of anti-tumor necrosis factor-α antibody-induced palmoplantar pustulosis with the Janus kinase inhibitor baricitinib in a patient with rheumatoid arthritis

J Dermatol. 2021 May;48(5):e240-e241. doi: 10.1111/1346-8138.15860. Epub 2021 Mar 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Arthritis, Rheumatoid* / drug therapy
  • Azetidines* / adverse effects
  • Humans
  • Janus Kinase 1
  • Janus Kinase 2
  • Janus Kinase Inhibitors* / therapeutic use
  • Purines
  • Pyrazoles
  • Sulfonamides / adverse effects

Substances

  • Antirheumatic Agents
  • Azetidines
  • Janus Kinase Inhibitors
  • Purines
  • Pyrazoles
  • Sulfonamides
  • Janus Kinase 1
  • Janus Kinase 2
  • baricitinib